
Results
9
Companies which are more than 50% undervalued based on analyst price target.
9 companies
Kinepolis Group
Market Cap: €711.5m
Operates and manages cinemas in Belgium, France, Canada, Spain, the Netherlands, the United States, Luxembourg, and internationally.
KIN
€26.60
7D
-3.1%
1Y
-28.3%
Hyloris Pharmaceuticals
Market Cap: €205.0m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€7.32
7D
-4.4%
1Y
38.1%
Onward Medical
Market Cap: €184.8m
A medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI).
ONWD
€4.14
7D
-1.2%
1Y
-29.2%
Nyxoah
Market Cap: €162.0m
A medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA).
NYXH
€3.77
7D
-5.8%
1Y
-63.8%
Atenor
Market Cap: €159.1m
Operates as a real estate development company in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, Britain, and Romania.
ATEB
€2.62
7D
-0.8%
1Y
-16.8%
Biotalys
Market Cap: €107.3m
An agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally.
BTLS
€2.86
7D
11.3%
1Y
-11.2%
Agfa-Gevaert
Market Cap: €75.9m
Develops, manufactures, and markets various analog and digital systems worldwide.
AGFB
€0.49
7D
2.2%
1Y
-46.7%
Sequana Medical
Market Cap: €39.3m
Develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally.
SEQUA
€0.55
7D
-7.2%
1Y
-67.6%
Belysse Group
Market Cap: €28.4m
Manufactures and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally.
BELYS
€0.79
7D
0%
1Y
29.5%